BMI Classifications

Underweight

Normal Weight

Overweight

Obese

Cohort

NJBRFS

Cohort

NJBRFS

Cohort

NJBRFS

Cohort

NJBRFS

Obs (% of 151)

Exp

Obs/Exp

p-value

95% CI

Obs (% of 151)

Exp

Obs/Exp

p-value

95% CI

Obs (% of 151)

Exp

Obs/Exp

p-value

95% CI

Obs (% of 151)

Exp

Obs/Exp

p-value

95% CI

Overall

7

(4.6)

1.99

3.52

0.009**

1.41-7.25

40 (26.5)

42.9

0.93

0.731

0.67-1.27

40 (26.5)

56.8

0.70

0.024*

0.50-0.96

64

(42.4)

49.3

1.30

0.049*

1.00-1.66

Hispanic

1

(0.7)

0.39

2.58

0.642

0.07-14.40

7

(4.6)

8.30

0.84

0.824

0.34-1.74

9 (6.0)

14.7

0.61

0.158

0.28-1.16

17 (11.3)

10.5

1.62

0.081

0.94-2.59

Black NH

4

(2.6)

0.60

6.71

0.007**

1.83-17.18

14 (9.3)

11.7

1.20

0.578

0.65-2.01

14 (9.3)

22.3

0.63

0.084

0.34-1.05

27 (17.9)

24.4

1.11

0.649

0.73-1.61

White NH

2

(1.3)

0.86

2.34

0.422

0.28-8.45

19 (12.6)

21.8

0.87

0.642

0.52-1.36

15 (9.9)

18.8

0.80

0.463

0.45-1.32

19 (12.6)

13.6

1.40

0.194

0.84-2.18

Male

3

(2.0)

0.40

7.44

0.016*

1.54-21.76

16 (10.6)

13.1

1.22

0.496

0.70-1.98

22 (14.6)

29.0

0.76

0.224

0.48-1.15

21 (13.9)

19.5

1.08

0.789

0.67-1.65

Female

4

(2.6)

1.59

2.52

0.154

0.69-6.45

24 (15.9)

29.8

0.81

0.334

0.52-1.20

18 (11.9)

27.9

0.65

0.063

0.38-1.02

43 (28.5)

29.8

1.44

0.026*

1.05-1.95

21-35

1

(0.7)

0.55

1.83

0.844

0.05-10.17

9

(6.0)

10.7

0.84

0.750

0.38-1.60

4 (2.6)

6.79

0.59

0.386

0.16-1.51

9

(6.0)

4.97

1.81

0.132

0.83-3.44

36-40

1

(0.7)

0.19

5.26

0.346

0.13-29.33

4

(2.6)

5.02

0.80

0.875

0.22-2.04

5 (3.3)

7.60

0.66

0.461

0.21-1.54

8

(5.3)

5.18

1.54

0.306

0.67-3.04

41-45

1

(0.7)

0.11

9.26

0.205

0.23-51.59

4

(2.6)

3.83

1.04

1.000

0.28-2.67

2 (1.3)

4.38

0.46

0.376

0.06-1.65

5

(3.3)

3.68

1.36

0.619

0.44-3.17

46-50

N.C.

N.C.

N.C.

N.C.

N.C.

2

(1.3)

4.99

0.40

0.250

0.05-1.45

5 (3.3)

7.86

0.64

0.409

0.21-1.49

14 (9.3)

7.96

1.76

0.066

0.96-2.95

51-55

1

(0.7)

0.28

3.57

0.488

0.09-19.90

8

(5.3)

6.40

1.25

0.626

0.54-2.46

6 (4.0)

9.66

0.62

0.306

0.23-1.35

11 (7.3)

9.64

1.14

0.743

0.57-2.04

56-60

1

(0.7)

0.40

2.53

0.653

0.06-14.11

7

(4.6)

6.05

1.16

0.803

0.47-2.38

7 (4.6)

10.1

0.70

0.429

0.28-1.43

11 (7.3)

9.49

1.16

0.706

0.58-2.08

61-65

N.C.

N.C.

N.C.

N.C.

N.C.

4

(2.6)

3.97

1.01

1.000

0.27-2.58

7 (4.6)

6.74

1.04

1.000

0.42-2.14

5

(3.3)

5.08

0.99

0.794

0.32-2.30

66-85

N.C.

N.C.

N.C.

N.C.

N.C.

2

(1.3)

1.95

1.03

1.000

0.12-3.71

N.C.

N.C.

N.C.

N .C.

N.C.

1

(0.7)

3.26

0.31

0.327

0.01-1.71

Younger Group

(Subjects ≤50)

3

(2.0)

1.00

3.01

0.160

0.62-8.79

18 (11.9)

24.2

0.74

0.239

0.44-1.18

16 (10.6)

26.3

0.61

0.043*

0.35-0.99

36 (23.8)

21.4

1.68

0.005**

1.18-2.32

Older Group

(Subjects >50)

4

(2.6)

0.99

4.03

0.037*

1.10-10.31

22 (14.6)

18.7

1.18

0.501

0.74-1.78

24 (15.9)

30.5

0.79

0.274

0.50-1.17

28 (18.5)

27.8

1.01

1.000

0.67-1.46

PWID

5

(3.3)

1.21

4.15

0.016*

1.35-9.68

23 (15.2)

30.7

0.75

0.183

0.47-1.12

25 (16.6)

30.7

0.81

0.345

0.53-1.20

29 (19.2)

23.8

1.22

0.334

0.82-1.75

Non-PWID

2

(1.3)

0.79

2.55

0.372

0.31-9.20

17 (11.3)

16.7

1.02

1.000

0.59-1.63

15 (9.9)

26.1

0.58

0.027*

0.32-0.95

35 (23.2)

25.4

1.38

0.083

0.96-1.91